108 related articles for article (PubMed ID: 10048397)
1. Interference between effector RNAs expressed from conventional dual-function anti-HIV retroviral vectors can be circumvented using dual-effector-cassette retroviral vectors.
Peng H; Callison D; Li P; Burrell CJ
Hum Gene Ther; 1999 Feb; 10(3):449-62. PubMed ID: 10048397
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
[TBL] [Abstract][Full Text] [Related]
3. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
4. Additive and antagonist effects of therapeutic gene combinations for suppression of HIV-1 infection.
Gennari F; Biasolo MA; Cancellotti E; Radaelli A; De Giuli Morghen C; Bozzoni I; Cereda PM; Mengoli C; Palù G; Parolin C
Antiviral Res; 2002 Jul; 55(1):77-90. PubMed ID: 12076753
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication by an anti-tat hammerhead ribozyme.
Jackson WH; Moscoso H; Nechtman JF; Galileo DS; Garver FA; Lanclos KD
Biochem Biophys Res Commun; 1998 Apr; 245(1):81-4. PubMed ID: 9535787
[TBL] [Abstract][Full Text] [Related]
6. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
[TBL] [Abstract][Full Text] [Related]
7. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
Ilves H; Barske C; Junker U; Böhnlein E; Veres G
Gene; 1996 Jun; 171(2):203-8. PubMed ID: 8666273
[TBL] [Abstract][Full Text] [Related]
9. Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.
Goodrich A; Parveen Z; Dornburg R; Schnell MJ; Pomerantz RJ
Mol Ther; 2004 Apr; 9(4):557-65. PubMed ID: 15093186
[TBL] [Abstract][Full Text] [Related]
10. Retroviral delivery and anti-HIV testing of hammerhead ribozymes.
Cagnon L; Rossi J
Methods Mol Biol; 1997; 74():451-7. PubMed ID: 9204460
[No Abstract] [Full Text] [Related]
11. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
[TBL] [Abstract][Full Text] [Related]
13. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1.
Morris KV; Looney DJ
Hum Gene Ther; 2005 Dec; 16(12):1463-72. PubMed ID: 16390277
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
16. A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.
Biasolo MA; Radaelli A; Del Pup L; Franchin E; De Giuli-Morghen C; Palu G
J Virol; 1996 Apr; 70(4):2154-61. PubMed ID: 8642637
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo transduction and expansion of CD4+ lymphocytes from HIV + donors: prelude to a ribozyme gene therapy trial.
Leavitt MC; Yu M; Wong-Staal F; Looney DJ
Gene Ther; 1996 Jul; 3(7):599-606. PubMed ID: 8818647
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors.
Boden D; Pusch O; Lee F; Tucker L; Ramratnam B
Mol Ther; 2004 Mar; 9(3):396-402. PubMed ID: 15006606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]